new glp 1 agonist Trends in the Development of GLP-1 Receptor Agonists America's Poison Centers - GLP-1
Description
Recuperato da: Thomsen M, Dencker D, Wrtwein G, Weikop P, Egecioglu E, Jerlhag E, et al
In particular, the positive impact on maximal effect (E max ) in this assay format significantly improves the chances of identifying weak agonists during high-throughput screening (HTS)
If recent meta-analyses were available, these were reported preferentially
hCAECs, human coronary artery endothelial cells
